Albumin Infusion Threshold for Hypoalbuminemia
The threshold for initiating albumin infusion in patients with hypoalbuminemia is generally when serum albumin levels fall below 2.5 g/dL, particularly when associated with clinical symptoms of hypovolemia or in specific clinical conditions. 1, 2
Clinical Decision Framework for Albumin Infusion
Primary Considerations
- Albumin infusion should focus on treating the underlying cause of hypoalbuminemia rather than simply correcting low albumin levels 2
- Serum albumin <2.5 g/dL is considered a predictor of severe disease in many clinical contexts 1
- Hypoalbuminemia is associated with increased mortality risk, with each decrease of 1.0 g/dL increasing mortality odds by 137% 2, 3
Specific Clinical Scenarios Where Albumin Infusion Is Indicated
Symptomatic Hypovolemia with Hypoalbuminemia
Liver Disease Complications
Congenital Nephrotic Syndrome
Critical Illness
- Both 4-5% (iso-oncotic) and 20% (hyperoncotic) albumin solutions can be used as second-line therapy to improve blood pressure in critically ill patients 4
- The Surviving Sepsis Campaign suggests using albumin in addition to crystalloids only in sepsis and septic shock patients requiring large volumes of saline 4
When Albumin Infusion Is Not Recommended
- Not recommended for first-line volume replacement in most critically ill adult patients 2
- Not recommended simply to increase serum albumin levels in critically ill patients with thermal injuries or ARDS 2
- Not recommended in conjunction with diuretics for removal of extravascular fluid 2
- Simple albumin infusion for patients with moderate to severe hypoalbuminemia did not significantly improve survival in acute surgical patients 5
Administration Guidelines
- For hypoproteinemia with or without edema, the usual daily dose of albumin for adults is 50 to 75 g and for children 25 g 6
- Rate of administration should not exceed 2 mL per minute in hypoproteinemic patients to avoid circulatory embarrassment and pulmonary edema 6
- In patients with severe hypoproteinemia who continue to lose albumin, larger quantities may be required 6
Monitoring and Follow-up
- Serum albumin concentration should be monitored regularly with a stable or rising value as the goal 1
- Evaluate serum albumin levels in the context of the patient's overall clinical status including comorbid diseases 1
- For dialysis patients, a predialysis or stabilized serum albumin equal to or greater than the lower limit of normal range (approximately 4.0 g/dL for the bromcresol green method) is the outcome goal 1
Special Considerations
- Hypoalbuminemia is associated with increased risk of venous thromboembolism (RR 1.88) and arterial events including myocardial infarction (RR 1.88) and stroke (RR 1.77) 7
- In peritoneal dialysis patients, serum albumin levels <3.8 g/dL are associated with higher risk of contrast-induced nephropathy 8
- In heart failure patients, hypoalbuminemia (≤3.5 g/dL) is associated with poor outcomes and increased mortality 9
Pitfalls and Caveats
- Albumin is not a nutritional supplement and should not be considered as a source of nutrition 6
- Albumin infusion is expensive and has potential adverse effects including fluid overload, hypotension, and anaphylaxis 2
- Serum albumin may be a marker of inflammation rather than nutritional status in many acute conditions 1
- The presence of acute or chronic inflammation limits the specificity of serum albumin as a nutritional marker 1
Remember that while 2.5 g/dL is a commonly used threshold, the decision to initiate albumin infusion should consider the clinical context, underlying cause of hypoalbuminemia, and presence of symptoms rather than relying solely on a specific albumin level.